These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1461 related items for PubMed ID: 18662762

  • 21. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B, Bal SM, Que I, Kaijzel E, Löwik C, Bouwstra J, Jiskoot W.
    Mol Pharm; 2010 Dec 06; 7(6):2207-15. PubMed ID: 21043518
    [Abstract] [Full Text] [Related]

  • 22. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
    Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS, Jaganathan KS.
    Vaccine; 2011 Jul 12; 29(31):4953-62. PubMed ID: 21575664
    [Abstract] [Full Text] [Related]

  • 23. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S, Saupe A, McBurney W, Rades T, Hook S.
    J Pharm Pharmacol; 2008 Dec 12; 60(12):1591-600. PubMed ID: 19000363
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M, Saluja V, Kersten GF, Kraan H, Slütter B, Amorij JP, Jiskoot W.
    Vaccine; 2012 Aug 03; 30(36):5341-8. PubMed ID: 22749834
    [Abstract] [Full Text] [Related]

  • 25. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ.
    Eur J Pharm Biopharm; 2004 Jan 03; 57(1):123-31. PubMed ID: 14729088
    [Abstract] [Full Text] [Related]

  • 26. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
    Amin M, Jaafari MR, Tafaghodi M.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):225-9. PubMed ID: 19699067
    [Abstract] [Full Text] [Related]

  • 27. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
    Hagenaars N, Mania M, de Jong P, Que I, Nieuwland R, Slütter B, Glansbeek H, Heldens J, van den Bosch H, Löwik C, Kaijzel E, Mastrobattista E, Jiskoot W.
    J Control Release; 2010 May 21; 144(1):17-24. PubMed ID: 20100528
    [Abstract] [Full Text] [Related]

  • 28. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
    Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W.
    J Control Release; 2006 Mar 10; 111(1-2):107-16. PubMed ID: 16380189
    [Abstract] [Full Text] [Related]

  • 29. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
    Wang S, Jiang T, Ma M, Hu Y, Zhang J.
    Int J Pharm; 2010 Feb 15; 386(1-2):249-55. PubMed ID: 19900520
    [Abstract] [Full Text] [Related]

  • 30. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
    Verheul RJ, Slütter B, Bal SM, Bouwstra JA, Jiskoot W, Hennink WE.
    J Control Release; 2011 Nov 30; 156(1):46-52. PubMed ID: 21784113
    [Abstract] [Full Text] [Related]

  • 31. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
    Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T.
    J Control Release; 2007 Aug 28; 121(3):168-75. PubMed ID: 17644205
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 38. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
    Bal SM, Slütter B, Jiskoot W, Bouwstra JA.
    Vaccine; 2011 May 23; 29(23):4025-32. PubMed ID: 21443959
    [Abstract] [Full Text] [Related]

  • 39. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W.
    J Control Release; 2010 Apr 19; 143(2):207-14. PubMed ID: 20074597
    [Abstract] [Full Text] [Related]

  • 40. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F, Zhang ZR, Huang Y.
    Int J Pharm; 2007 May 04; 336(1):166-73. PubMed ID: 17145144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 74.